Anterix (ATEX) Current Deferred Revenue (2014 - 2026)

Anterix (ATEX) has reported Current Deferred Revenue for 13 consecutive years, with $174.9 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Current Deferred Revenue rose 36.42% year-over-year to $174.9 million; the trailing twelve-month figure through Jun 2026 stood at $174.9 million (up 36.42% YoY), and the FY2026 full-year result was $161.2 million, up 29.28% from the prior year.
• Current Deferred Revenue climbed to $174.9 million in Q2 2026 per ATEX's latest filing, from $161.2 million in the prior quarter.
• Across five years, Current Deferred Revenue topped out at $174.9 million in Q2 2026 and bottomed at $53.9 million in Q3 2022.
• Historically, Current Deferred Revenue has averaged $104.5 million across 5 years, with a median of $121.4 million in 2024.
• The sharpest annual moves came in 2022 and 2025: Current Deferred Revenue soared 7273.54% in 2022, then gained 2.01% in 2025.
• Over 5 years, Current Deferred Revenue stood at $61.4 million in 2022, then soared by 74.46% to $107.1 million in 2023, then climbed by 17.75% to $126.1 million in 2024, then grew by 5.18% to $132.6 million in 2025, then surged by 31.91% to $174.9 million in 2026.
• According to Business Quant data, Current Deferred Revenue over the past three periods registered $174.9 million, $161.2 million, and $132.6 million for Q2 2026, Q1 2026, and Q4 2025 respectively.